Dental Pulp Exposure Clinical Trial
Official title:
Mineral Trioxide Aggregate (MTA) vs. Calcium Hydroxide (CaOH) in Direct Pulp Capping in NW PRECEDENT (Northwest Practice-based REsearch Collaborative in Evidence-based DENTistry Practices.
The purpose of this study is to determine if MTA or calcium hydroxide are more effective as pulp capping agents
The purpose of this study was to test two dental products used as direct pulp capping agent
for the permanent teeth. The two products were mineral trioxide aggregate and calcium
hydroxide.
A direct pulp capping consists of covering an exposed tooth pulp (the inside portion of the
tooth where the blood vessels and nerve supply the tooth) with a medication to maintain
tooth vitality. Different events can cause the pulp to be exposed, for example a deep
cavity, or an accident where the outer portion of the tooth fractures. When this occurs, it
is sometimes possible to place a medicine over the top of the exposure (a "cap") in an
effort to allow the pulp to heal on its own. Our study intended to compare two of those
medicines, calcium hydroxide and mineral trioxide aggregate, both Federal Drug
Administration (FDA) approved products, to determine if one performed better than the other.
The study was conducted with patients recruited by Northwest PRECEDENT practitioners. The
practitioners interested in participating in the study were randomized (assigned by chance)
to one of the two intervention groups: a treatment group (mineral trioxide aggregate) and a
control group (calcium hydroxide).
Direct pulp capping was completed on permanent (adult) teeth with pulps exposed due to
decay, trauma (injury) or mechanical exposure. Treated teeth were followed over two years to
determine how well they responded to the treatment.
All patients who had a pulp exposure of a permanent tooth were eligible for the study. These
patients were further asked to participate in the study if they satisfied the inclusion
criteria for the study and did not present any of the exclusion criteria stated in the study
protocol.
A tooth that received a pulp cap was treated in the following manner: After a tooth pulp had
been exposed and the tooth was found to be suitable for a pulp cap, the exposure and
surrounding area was cleaned by gentle rinsing with water. A cotton pellet moistened with
5.25% sodium hypochlorite was placed over the exposure and allowed to sit for 1-2 minutes.
This procedure was used to control pulp bleeding and remove the germs from that area. After
the initial period, the cotton pellet was removed and the area inspected. If bleeding
continued, a new cotton pellet moistened in the sodium hypochlorite solution was reapplied
to the area for an additional several minutes. This was repeated until bleeding was
controlled or the practitioner decided that pulp capping was not appropriate for the
situation. Once the bleeding was controlled from the exposure, one of the two pulp capping
agents was applied to the pulp exposure site.
Practices were assigned by chance into one of two treatment groups, those that completed
direct pulp capping with mineral trioxide aggregate and those that completed direct pulp
capping with calcium hydroxide, both FDA approved agents for this purpose. The handling
characteristics of the two materials were so different, that it was not practical to blind
the practitioners as to which material they were using. Likewise, training in the use of
each material was required. It was believed that it was more important that the practitioner
become familiar and competent in the use of one of the materials to ensure it was used
appropriately, than it was to have practitioners use both materials and confuse procedures
between them. Since time was a critical element in the success or failure of direct pulp
capping, the patients were consented to participate in the study after the procedure was
done. A resin-modified glass ionomer liner (e.g. Vitrebond, Fuji Lining Cement, Fuji II LC,
Vitremer) was placed over the pulp capping agent. This liner sealed the pulp capping agent
and protected the pulp from being infiltrated with bacteria. After the resin-modified glass
ionomer lining material was set, the final filling was placed.
Two types of instruments were used in this study:
Study participant data collection form This form collected two types of data: demographic
and clinical data. The demographic part gathered information regarding patient age, gender,
and race. The clinical form collected data regarding the clinical and x-ray evaluation of
the tooth treated with a direct pulp cap: condition of the tooth, the type of pulp exposure
(by decay, by injury or during tooth preparation), patients' complaints regarding the tooth,
and results of diagnostic tests (x-ray, pain to biting or temperature, etc) were recorded.
Practitioner feedback survey A survey was administered to all practitioners who participated
in the study. This survey included a series of questions designed to evaluate the
communication between the member practitioners and the network, practitioner/staff training,
patient recruitment, obtaining informed consent, data collection and data transmission,
including the electronic data capture system. The survey also tried to determine how well
the offices were able to combine the research in a regular daily office schedule in order to
determine if a research project would affect the normal day-to-day routine.
The intent of this study was to find out which of the two products yielded better results as
a pulp capping agent. In order to detect this, the failure rates in the two treatment groups
were compared using statistical tests. Distributions of covariates in the two treatment
groups were compared and clinical judgment was used to identify covariates with serious
group imbalances that would cause an unusual result for the primary analysis. Logistic
regression was used to compare failure rates while adjusting for any covariates that were
imbalanced between groups.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02019563 -
MTA/FS Pulpotomy for Vital Primary Incisors: A Randomized Controlled Trial
|
Phase 2 | |
Not yet recruiting |
NCT04330768 -
Platelet Rich Fibrin(PRF) Injection for Treatment of Dental Pulp Exposure:Randomized Clinical Trial
|
N/A | |
Completed |
NCT02789423 -
Clinical & Radiographical Evaluation of the Effect of Dycal & Biodentine in DPC in Primary Teeth
|
N/A | |
Completed |
NCT01468480 -
Human Pulpal Response After Pulp Capping With Four Different Agents
|
Phase 2/Phase 3 | |
Completed |
NCT02487329 -
The Effect of Laser Combined With Pulp-capping Agents on Direct Pulp Capping
|
N/A | |
Completed |
NCT00187850 -
The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy
|
N/A | |
Completed |
NCT03631511 -
Histological Evaluation of Hard Tissue Formation After Direct Pulp Capping With RetroMTA
|
N/A | |
Completed |
NCT02492841 -
Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth
|
Phase 2/Phase 3 |